21 Apr 2015

Event Report: Launch of European Biopharmaceutical Enterprises (EBE) and Vital Transformation Report, “Europe’s Emerging Science: Putting Advanced Therapies into Practice to Deliver Better Health”

On 15 April, thought leaders met in Lyon, France to take part in a panel discussion and Q&A on the potential of advanced therapies and the challenges we face in implementing them in Europe. The ev...

Read more
27 Mar 2015

WEBINAR: Stem Cells, Gene Therapies, and Tissue Engineering: How do we Put Advanced Therapies into Practice in Europe?

On 16 March, EBE, in collaboration with Vital Transformation and BioVision, held the webinar "Stem Cells, Gene Therapies, and Tissue Engineering: How do we Put Advanced Therapies into Practice in Europe?" in support of the new report on Advanced Therapies being released by EBE and Vital Transformation in Lyon, April 15th at the BioVision conference. The webinar materials and recording are now available for download. ...

Read more
03 Feb 2015

New EBR article by EBE

The January 2015 edition of the European Biopharmaceutical Review (EBR) is now live. Published quarterly, EBR provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world. For our article on the funding challenges of the biopharmaceutical industry please click here. To read the full magazine, please click here....

Read more
30 Nov 2014

EBE and ESCHER launched new project ‘Pharmacovigilance of biologics’

Escher, the TI Pharma platform for regulatory innovation, launched a new project,‘Pharmacovigilance of biologics’ in November 2014. It will address the challenges of product and batch traceability...

Read more
13 Nov 2014


Booklet Annex ...

Read more
11 Jul 2014

EBE Welcomes the Second Innovative Medicines Initiative – A message from Roberto Gradnik

(Brussels, 11 July 2014) Dear all, I had the pleasure of attending this weeks launch event of, the Innovative Medicines Initiative (IMI)2 and delighted to share with you the good new...

Read more
05 Jun 2014

EBE comments on quality guideline (EMA/CHMP/BWP/247713/2012)

In June 2014, EMA published the final version of the Quality guidelines, following approval by Committee for Medicinal Products for Human Use (CHMP) at the end of May 2014.  14 stakeholders submitted comments. European Biopharmaceutical Enterprises (EBE), stakeholder No 5, of a total of 43 comments, 25 were accepted / partly accepted / acknowledged, while some 18 were not accepted....

Read more
02 Apr 2014

Biopharmaceutical SMEs convene to discuss funding strategies

Last week, on 27 March 2014, 65 SMEs and stakeholders in Biopharmaceutical Innovation met to discuss public funding strategies for small companies at a workshop in Brussels organised by European Biopharmaceutical Enterprises, EBE, and European Biotechnology Network, EBN, two organisations that support SME-driven life science development....

Read more
27 Sep 2013

EMA – European Medicines Agency organising workshop on biosimilars

The European Medicines Agency is holding a workshop on biosimilars on 31 October 2013 in London. The Agency is organising this workshop as part of its public-consultation exercise on its three draft revised overarching guidelines on biosimilars....

Read more
15 Aug 2013

World health report 2013: Research for universal health coverage

The main purpose of the report is to provide countries, donor agencies, international organizations and others with the information they need to help them make policy and funding decisions. The report is also offered to a wider audience, from universities, teaching hospitals and schools, to journalists and the public at large - anyone, in fact, with a professional or personal interest in international health issues....

Read more
1 5 6 7 8